Running from November 8-9, 2021 in Miami, Wonderland was an impressive collection of scientists and researchers, investors and entrepreneurs, therapists and patients, government officials, and media — all championing the growth of the psychedelic medicine industry.
From heavyweight celebrities like Mike Tyson, to the industry’s top companies and insiders, Wonderland was the sector’s largest in-person event. The psychedelic medicine industry has officially arrived and we’re proud to be a part of it.
Pulling off such a massive undertaking wouldn’t be possible without the support of our sponsors, they are crucial to both the Wonderland event and the future of the psychedelic medicine industry.
Here’s a summary of Platinum Sponsor Alvarius Pharmaceuticals and their participation at Wonderland.
In addition to their generous financial support, Alvarius Pharmaceuticals also participated in important industry panels:
“The Magical Mystery Tour”
The team from Alvarius took the stage to discuss the state of the industry and their company’s developments. Speakers included:
- James Linden, CEO
- Daniel Robin, Clinical Operations and Business Development Officer
- Helen McCormack, Clinical and Commercial Operations
- Professor Keith Murphy, Founder & Scientific Advisor
About the sponsor:
Alvarius is an Irish bio-pharmaceutical company researching and developing unique therapies to target addiction through the pioneering use of 5-MeO-DMT medicines. Alvarius aims to help patients overcome addictive substance-related behaviours with ground-breaking pharmaceutical solutions combined with tailored therapy.
Together with our collaboration partners in University College Dublin, we are utilizing the latest scientific methods to unlock the potential of psychedelics and associated therapy in treating addiction and other mental illnesses, and exploring the many associated benefits of these underused, misunderstood, and often stigmatized substances.
The therapy includes acute administration of 5-MeO-DMT coupled with expertly guided psychotherapy sessions designed to maximize the anti-addictive benefits of the psychedelic treatment.
